AI
BPTH

Analytic Investors’s Bio-Path Holdings Inc BPTH Stock Holding History

Analytic Investors’s Portfolio BPTH Stock Details BPTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-30
Closed -$214K – 628
2015
Q1 		$214K Buy
30
+5
+20% +$42K ﹤0.01% 516
2014
Q4 		$270K Buy
25
+8
+47% +$82.6K ﹤0.01% 487
2014
Q3 		$139K Buy
+17
New +$164K ﹤0.01% 576

Other funds holding BPTH

UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Analytic Investors's BPTH Position: Q2 2015 in Review

Analytic Investors sold out of Bio-Path Holdings Inc (BPTH) in Q2 2015, closing a stake of 30 shares — an estimated $214K sold.

Analytic Investors first reported a position in BPTH in Q3 2014 and held it in 3 quarters. The position peaked at $270K in Q4 2014. 33 funds tracked by Wall St. Rank hold BPTH as of Q2 2015.

  • Analytic Investors reported no remaining Bio-Path Holdings Inc position as of Q2 2015 after selling out during the quarter.
  • Analytic Investors sold 30 Bio-Path Holdings Inc shares in Q2 2015, an estimated $214K.
  • Analytic Investors first reported a position in Bio-Path Holdings Inc in Q3 2014 and held it in 3 quarters.
  • Analytic Investors's Bio-Path Holdings Inc position peaked at $270K in Q4 2014.
  • 33 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q2 2015.

Based on Analytic Investors's 13F filing for Q2 2015, filed 12 Aug 2015.